Serum growth differentiation factor 15 is a novel biomarker with high predictive capability for liver cancer occurrence in patients with <scp>MASLD</scp> regardless of liver fibrosis
Shusuke Kumazaki(Osaka Gakuin University), Tetsuo Takehara(Osaka Gakuin University), Goki Suda(Sapporo University), Hidenori Toyoda(Ogaki Municipal Hospital), Yoshinobu Saito(Osaka Gakuin University), Kazuhiro Murai(The University of Osaka), Yuki Tahata(Osaka Gakuin University), Yutaka Sasaki(Iwate Medical University), Eiichi Morii(The University of Osaka), Yōichi Sasaki(Osaka Hospital), Kenji Fukumoto(The University of Osaka), Takahiro Kodama(The University of Osaka), Naruyasu Kakita(Takarazuka City Hospital), Takeshi Ebihara(The University of Osaka), Takashi Kojima(The University of Osaka), Ji Hyun Sung(The University of Osaka), Hayato Hikita(Osaka Gakuin University), Sadatsugu Sakane(The University of Osaka), Tomohide Tatsumi(The University of Osaka), Kumiko Shirai(The University of Osaka), Kentaro K. Shimizu(Kihara Institute for Biological Research), Hirokazu Takahashi(Saga University), Yuta Myojin(Osaka Gakuin University)
Cited by 20
Related Papers
aMAP risk score predicts hepatocellular carcinoma development in patients with chronic hepatitis
|Journal of Hepatology|2020|346
The wheat powdery mildew genome shows the unique evolution of an obligate biotroph
|Nature Genetics|2013|252
Sequencing of the genus Arabidopsis identifies a complex history of nonbifurcating speciation and abundant trans-specific polymorphism
|Nature Genetics|2016|222